30 September 2019 - Real-world evidence is increasingly valued by regulators and payers. 

Central to this evidence base is patient-reported outcome data describing the impact of drugs on quality of life, daily activities and symptoms. 

Here, we highlight key challenges with current real-world, patient-reported outcome data and describe collaborative next steps for international stakeholders to overcome these issues.

Read Nature Reviews Drug Discovery article